Complete Filing Data
Privia Health Group, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $790.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Privia Health Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | $22.9M | $14.4M | $23.1M | -$8.6M | -$188.2M | $31.2M | $8.2M |
| Selling And Marketing Expense | $27.1M | $26.4M | $24.7M | $19.7M | $22.8M | $11.3M | $9.2M |
| Revenue From Contract With Customer Including Assessed Tax | $2.12B | $1.74B | $1.66B | $1.36B | $966.2M | $817.1M | $786.4M |
| Operating Income Loss | $34.2M | $17.0M | $20.6M | -$19.1M | -$217.4M | $25.4M | $16.1M |
| Operating Expenses | $2.09B | $1.72B | $1.64B | $1.38B | $1.18B | $791.7M | $770.3M |
| Net Income Loss Attributable To Noncontrolling Interest | $6.8M | $2.7M | -$2.1M | -$3.5M | -$2.4M | -$340.0K | -$299.0K |
| Income Tax Expense Benefit | $14.2M | $10.8M | $8.0M | -$6.5M | -$27.9M | -$7.4M | $1.2M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $43.9M | $27.9M | $29.0M | -$18.6M | -$218.5M | $23.5M | $9.2M |
| General And Administrative Expense | $138.2M | $126.2M | $109.6M | $129.6M | $255.9M | $44.0M | $41.8M |
| Cost Of Platform | $252.7M | $227.0M | $197.7M | $170.8M | $174.7M | $105.0M | $95.3M |
| Amortization Of Intangible Assets | $9.2M | $6.2M | $5.4M | $3.4M | $1.3M | $642.0K | $643.0K |
| Deferred Income Tax Expense Benefit | $10.9M | $8.8M | $7.5M | -$7.0M | -$28.4M | -$7.8M | $716.0K |
| Interest Income Expense Net | $8.4M | $542.0K | -$1.1M | -$1.9M | -$6.9M | ||
| Income Taxes Paid Net | $6.6M | $3.8M | $1.0M | $307.0K | $504.0K | $381.0K | $316.0K |
| Deferred Income Tax Assets Net | $2.3M | $26.4M | $35.2M | $40.4M | $33.4M | $5.0M | |
| Nonoperating Income Expense | $9.7M | $10.9M | $8.4M | $542.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $6.9M | $2.7M | $4.2M | $3.5M | $3.5M | $3.0M | $5.6M | $7.3M | $7.3M | $1.6M | -$10.5M | -$17.5M | -$9.1M | -$172.5M | $5.4M | $16.7M | $5.3M | $5.4M |
| Selling And Marketing Expense | $7.0M | $6.8M | $6.9M | $7.0M | $6.9M | $6.1M | $7.2M | $6.0M | $5.3M | $5.1M | $4.8M | $4.7M | $4.6M | $11.2M | $3.2M | $2.7M | $2.2M | $2.5M |
| Revenue From Contract With Customer Including Assessed Tax | $580.4M | $521.2M | $480.1M | $437.9M | $422.3M | $415.2M | $417.3M | $413.4M | $386.3M | $342.9M | $335.5M | $313.8M | $251.5M | $225.8M | $213.6M | $207.2M | $183.3M | $212.9M |
| Operating Income Loss | $14.4M | $3.3M | $5.2M | $5.8M | $5.1M | $823.0K | $5.5M | $7.0M | $6.7M | -$4.6M | -$5.3M | -$11.5M | -$12.8M | -$193.2M | $7.9M | $8.5M | $6.2M | $6.5M |
| Operating Expenses | $566.0M | $517.8M | $474.9M | $432.1M | $417.2M | $414.4M | $411.7M | $406.4M | $379.6M | $347.5M | $340.8M | $325.3M | $264.3M | $418.9M | $205.7M | $198.6M | $177.1M | $206.4M |
| Net Income Loss Attributable To Noncontrolling Interest | $2.9M | $601.0K | $1.8M | $443.0K | $1.2M | $72.0K | $299.0K | -$914.0K | -$922.0K | -$1.1M | -$906.0K | -$577.0K | -$1.8M | -$951.0K | $218.0K | -$85.0K | -$85.0K | -$85.0K |
| Income Tax Expense Benefit | $6.9M | $2.5M | $2.1M | $4.0M | $3.4M | $751.0K | $2.5M | $1.4M | $2.1M | -$4.8M | $5.5M | $6.3M | -$2.2M | -$20.0M | $2.0M | -$8.6M | $474.0K | $700.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $16.7M | $5.7M | $8.1M | $8.0M | $8.1M | $3.8M | $8.4M | $7.8M | $8.5M | -$4.3M | -$5.9M | -$11.8M | -$13.1M | -$193.5M | $7.6M | $8.0M | $5.7M | $6.0M |
| General And Administrative Expense | $39.6M | $37.5M | $31.7M | $30.7M | $28.9M | $32.1M | $27.2M | $26.8M | $26.0M | $32.2M | $33.1M | $36.1M | $33.9M | $168.7M | $14.0M | $9.8M | $8.4M | $11.0M |
| Cost Of Platform | $61.4M | $64.9M | $59.5M | $56.1M | $57.1M | $54.1M | $50.3M | $50.2M | $44.7M | $43.8M | $42.4M | $41.3M | $35.3M | $68.7M | $27.0M | $25.2M | $24.3M | $27.6M |
| Amortization Of Intangible Assets | $2.6M | $2.4M | $1.7M | $1.5M | $1.5M | $1.5M | $1.4M | $1.4M | $1.0M | $800.0K | $900.0K | $812.0K | $200.0K | $200.0K | $160.0K | $200.0K | $200.0K | $161.0K |
| Deferred Income Tax Expense Benefit | $1.7M | $863.0K | $1.9M | $6.3M | $2.0M | $670.0K | ||||||||||||
| Interest Income Expense Net | $3.0M | $2.9M | $817.0K | $1.8M | $285.0K | -$663.0K | -$232.0K | -$292.0K | -$302.0K | -$291.0K | -$504.0K | -$509.0K | -$467.0K | |||||
| Income Taxes Paid Net | -$313.0K | -$230.0K | -$5.0K | |||||||||||||||
| Deferred Income Tax Assets Net | $17.0M | $23.7M | $24.7M | $27.6M | $31.3M | $34.3M | $35.2M | $37.1M | $38.5M | $26.8M | $21.8M | $27.1M | $25.4M | $23.2M | $3.0M | |||
| Nonoperating Income Expense | $2.3M | $2.4M | $2.9M | $2.2M | $3.0M | $3.0M | $2.9M | $817.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $737.2M | $635.2M | $561.4M | $499.1M | $426.9M | $146.7M | $107.5M | $86.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M | $84.6M | $46.9M | $39.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$11.5M | $101.6M | $41.5M | $27.4M | $235.9M | $37.7M | $7.8M | |
| Liability For Future Policy Benefits Period Expense | $1.66B | $1.33B | $1.30B | $1.05B | $727.8M | |||
| Increase Decrease Physician And Practice Liability | $32.9M | $113.4M | $67.7M | $33.9M | $24.5M | $15.6M | ||
| Retained Earnings Accumulated Deficit | -$156.3M | -$179.2M | -$193.6M | -$216.7M | -$208.1M | -$19.9M | ||
| Property Plant And Equipment Net | $504.0K | $1.2M | $2.3M | $3.4M | $4.5M | $4.8M | ||
| Prepaid Expense And Other Assets Current | $30.4M | $27.5M | $20.5M | $14.4M | $8.7M | $6.3M | ||
| Other Liabilities Noncurrent | $2.6M | $153.0K | $313.0K | $1.0M | $3.0M | $5.6M | ||
| Other Assets Noncurrent | $21.0M | $17.1M | $8.6M | $4.7M | $4.5M | $4.5M | ||
| Minority Interest | $53.7M | $48.3M | $46.0M | $20.0M | $23.3M | -$3.1M | ||
| Liabilities Noncurrent | $9.9M | $3.2M | $5.6M | $9.5M | $45.7M | $38.4M | ||
| Liabilities Current | $568.5M | $449.1M | $387.0M | $264.3M | $190.5M | $146.9M | ||
| Liabilities And Stockholders Equity | $1.37B | $1.14B | $999.9M | $792.8M | $686.4M | $329.0M | ||
| Liabilities | $578.4M | $452.3M | $392.5M | $273.8M | $236.2M | $185.3M | ||
| Goodwill | $209.8M | $141.6M | $138.7M | $126.9M | $127.9M | $118.7M | ||
| Finite Lived Intangible Assets Net | $215.9M | $109.8M | $107.6M | $57.4M | $59.7M | $6.0M | ||
| Common Stock Value | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $960.0K | ||
| Cash And Cash Equivalents At Carrying Value | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M | $84.6M | ||
| Assets Noncurrent | $458.4M | $301.0M | $299.1M | $240.9M | $239.7M | $138.9M | ||
| Assets Current | $911.0M | $834.8M | $700.8M | $552.0M | $446.7M | $190.1M | ||
| Assets | $1.37B | $1.14B | $999.9M | $792.8M | $686.4M | $329.0M | ||
| Accounts Receivable Net Current | $400.9M | $316.2M | $290.8M | $189.6M | $117.4M | $99.1M | ||
| Operating Lease Right Of Use Asset | $8.8M | $4.8M | $6.6M | $8.1M | $9.6M | $0.00 | ||
| Operating Lease Liability Noncurrent | $7.3M | $3.0M | $5.2M | $8.5M | $11.0M | $0.00 | ||
| Operating Lease Liability Current | $2.2M | $2.6M | $3.0M | $3.0M | $2.9M | $0.00 | ||
| Repayments Of Notes Payable | $0.00 | $0.00 | $33.3M | $875.0K | $875.0K | $30.0M | ||
| Accounts Payable And Accrued Liabilities Current | $96.8M | $82.0M | $57.8M | $52.8M | $46.0M | $39.3M | ||
| Amortization Addition Of Debt Issuance Costs | $0.00 | $0.00 | $687.0K | $157.0K | $134.0K | $332.0K | ||
| Liability For Unpaid Claims And Claims Adjustment Expense Net | $469.5M | $364.6M | $326.1M | $208.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $709.1M | $682.9M | $659.4M | $614.9M | $595.4M | $576.8M | $544.7M | $525.2M | $513.3M | $470.2M | $445.2M | $435.0M | $410.6M | $393.3M | $152.2M | $135.1M | $118.2M | $112.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $441.4M | $390.1M | $469.3M | $422.0M | $387.4M | $351.1M | $330.4M | $317.9M | $311.2M | $316.9M | $292.2M | $315.9M | $362.1M | $299.8M | $81.9M | $88.2M | $62.8M | $49.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$21.8M | -$38.4M | -$36.8M | -$4.6M | -$2.7M | $2.9M | |||||||||||||
| Liability For Future Policy Benefits Period Expense | $455.2M | $406.0M | $374.8M | $336.5M | $322.5M | $320.3M | $325.2M | $321.7M | $302.3M | $265.2M | $259.3M | $242.2M | $190.1M | $169.9M | $161.1M | ||||
| Increase Decrease Physician And Practice Liability | $35.7M | $24.2M | $51.9M | $31.6M | $17.0M | $7.3M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$165.5M | -$172.3M | -$175.0M | -$183.6M | -$187.2M | -$190.6M | -$196.5M | -$202.1M | -$209.4M | -$234.5M | -$236.1M | -$225.6M | -$196.1M | -$187.0M | -$14.5M | ||||
| Property Plant And Equipment Net | $662.0K | $827.0K | $1.0M | $1.5M | $1.7M | $2.0M | $2.6M | $2.9M | $3.1M | $3.7M | $4.0M | $4.2M | $4.3M | $4.4M | $4.5M | ||||
| Prepaid Expense And Other Assets Current | $30.5M | $48.8M | $28.4M | $22.8M | $22.3M | $30.9M | $17.2M | $16.2M | $16.7M | $16.4M | $15.2M | $10.4M | $8.9M | $9.8M | $6.0M | ||||
| Other Liabilities Noncurrent | $1.6M | $0.00 | $153.0K | $313.0K | $313.0K | $313.0K | $1.3M | $1.3M | $1.3M | $3.0M | $3.0M | $3.0M | $333.0K | $333.0K | $333.0K | ||||
| Other Assets Noncurrent | $16.9M | $16.7M | $16.9M | $15.0M | $15.2M | $15.4M | $6.9M | $4.7M | $4.7M | $4.0M | $3.1M | $3.3M | $3.4M | $3.1M | $5.8M | ||||
| Minority Interest | $53.6M | $50.7M | $50.1M | $47.3M | $48.2M | $46.0M | $46.4M | $46.1M | $43.2M | $20.9M | $22.0M | $22.9M | -$5.6M | -$3.8M | -$2.9M | ||||
| Liabilities Noncurrent | $5.3M | $4.1M | $3.2M | $3.9M | $4.4M | $5.0M | $7.1M | $7.8M | $9.1M | $12.2M | $12.7M | $44.9M | $39.8M | $40.4M | $41.4M | ||||
| Liabilities Current | $582.9M | $534.9M | $470.8M | $479.5M | $429.6M | $403.8M | $394.2M | $358.4M | $309.7M | $304.5M | $265.1M | $220.4M | $187.2M | $167.3M | $157.5M | ||||
| Liabilities And Stockholders Equity | $1.35B | $1.27B | $1.18B | $1.15B | $1.08B | $1.03B | $992.3M | $937.6M | $875.3M | $807.8M | $745.0M | $723.2M | $632.1M | $597.1M | $348.3M | ||||
| Liabilities | $588.2M | $539.0M | $474.0M | $483.4M | $434.0M | $408.8M | $401.3M | $366.3M | $318.8M | $316.7M | $277.9M | $265.3M | $227.1M | $207.7M | $198.9M | ||||
| Goodwill | $172.2M | $172.2M | $141.6M | $139.5M | $139.5M | $139.5M | $135.6M | $135.1M | $135.1M | $126.9M | $126.9M | $127.9M | $118.7M | $118.7M | $118.7M | ||||
| Finite Lived Intangible Assets Net | $167.5M | $170.1M | $108.1M | $103.1M | $104.6M | $106.1M | $107.2M | $96.2M | $97.6M | $58.2M | $59.1M | $58.9M | $5.5M | $5.7M | $5.8M | ||||
| Common Stock Value | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $960.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $441.4M | $390.1M | $469.3M | $422.0M | $387.4M | $351.1M | $330.4M | $317.9M | $311.2M | $316.9M | $292.2M | $315.9M | $362.1M | $299.8M | $81.9M | ||||
| Assets Noncurrent | $380.1M | $389.6M | $297.1M | $291.8M | $298.0M | $303.4M | $294.7M | $283.6M | $286.6M | $228.1M | $223.7M | $230.6M | $162.6M | $160.7M | $143.6M | ||||
| Assets Current | $970.9M | $883.0M | $886.5M | $853.8M | $779.7M | $728.1M | $697.7M | $654.0M | $588.8M | $579.6M | $521.3M | $492.6M | $469.4M | $436.5M | $204.6M | ||||
| Assets | $1.35B | $1.27B | $1.18B | $1.15B | $1.08B | $1.03B | $992.3M | $937.6M | $875.3M | $807.8M | $745.0M | $723.2M | $632.1M | $597.1M | $348.3M | ||||
| Accounts Receivable Net Current | $499.0M | $444.0M | $388.7M | $409.0M | $370.1M | $346.1M | $350.1M | $319.8M | $260.9M | $246.3M | $213.9M | $166.2M | $98.4M | $126.9M | $116.7M | ||||
| Operating Lease Right Of Use Asset | $5.7M | $6.0M | $4.7M | $5.3M | $5.7M | $6.2M | $7.1M | $7.6M | $7.6M | $8.5M | $8.8M | $9.2M | $5.4M | $5.6M | $5.9M | ||||
| Operating Lease Liability Noncurrent | $3.7M | $4.1M | $3.0M | $3.6M | $4.1M | $4.7M | $5.8M | $6.5M | $7.8M | $9.2M | $9.7M | $10.4M | $7.8M | $8.1M | $8.8M | ||||
| Operating Lease Liability Current | $2.6M | $2.5M | $2.4M | $2.6M | $2.6M | $2.9M | $3.2M | $3.2M | $3.0M | $3.0M | $2.9M | $2.9M | $2.2M | $2.2M | $2.2M | ||||
| Repayments Of Notes Payable | $0.00 | $219.0K | $219.0K | $0.00 | |||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $84.7M | $74.3M | $68.1M | $65.6M | $60.8M | $50.7M | $54.3M | $48.9M | $46.3M | $47.3M | $40.3M | $44.2M | |||||||
| Amortization Addition Of Debt Issuance Costs | $0.00 | $38.0K | $38.0K | $33.0K | |||||||||||||||
| Liability For Unpaid Claims And Claims Adjustment Expense Net | $495.7M | $458.1M | $400.3M | $411.3M | $366.1M | $350.3M | $336.6M | $306.4M | $260.4M | $254.3M | $221.9M | $172.3M | $140.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $9.9M | $7.3M | $6.5M | $4.6M | $2.5M | $1.8M | $1.4M |
| Stock Issued During Period Value Share Based Compensation | $2.7M | $8.7M | $13.4M | $3.8M | |||
| Share Based Compensation | $71.1M | $56.7M | $37.1M | $67.4M | $253.5M | $484.0K | $207.0K |
| Net Cash Provided By Used In Operating Activities | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M | $38.9M | $24.4M |
| Net Cash Provided By Used In Investing Activities | -$181.6M | -$12.0M | -$43.0M | -$104.0K | -$32.8M | -$380.0K | -$5.7M |
| Net Cash Provided By Used In Financing Activities | $6.7M | $4.3M | $3.7M | -$19.7M | $213.7M | -$767.0K | -$10.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.6M | $9.0M | $6.2M | $5.7M | $1.3M | $962.0K | $151.0K |
| Increase Decrease In Other Noncurrent Assets | $326.0K | $1.7M | $2.4M | -$1.4M | $9.7M | -$1.2M | $2.4M |
| Increase Decrease In Accounts Receivable | $36.7M | $19.8M | $96.9M | $72.2M | $14.6M | $21.8M | $6.2M |
| Increase Decrease In Operating Lease Liability | -$2.5M | -$2.7M | -$3.2M | -$2.4M | $13.9M | $0.00 | $0.00 |
| Proceeds From Stock Options Exercised | $8.0M | $2.7M | $8.7M | $13.4M | $3.8M | $108.0K | $0.00 |
| Increase Decrease In Other Noncurrent Liabilities | $2.4M | -$160.0K | -$1.0M | -$2.0M | -$5.5M | $672.0K | $4.8M |
| Increase Decrease In Accounts Payable | $14.8M | $19.9M | $5.0M | $6.9M | $1.3M | ||
| Payments To Acquire Businesses Net Of Cash Acquired | $180.4M | $7.0M | $42.9M | $0.00 | $32.2M | $0.00 | $0.00 |
| Proceeds From Minority Shareholders | $0.00 | $1.7M | $659.0K | $125.0K | $0.00 | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $113.0K | $104.0K | $547.0K | $380.0K | $5.7M | ||
| Proceeds From Issuance Initial Public Offering | $0.00 | $0.00 | $223.7M | $0.00 | $0.00 | ||
| Payments Of Stock Issuance Costs | $0.00 | $0.00 | $12.7M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $2.8M | $2.6M | $1.9M | $1.8M | $1.8M | $1.8M | $1.7M | $1.7M | $1.3M | $1.2M | $1.2M | $1.1M | $466.0K | $440.0K | $445.0K | $457.0K | $594.0K | $338.0K |
| Stock Issued During Period Value Share Based Compensation | $431.0K | $1.9M | $2.2M | $838.0K | $749.0K | $475.0K | $3.0M | $4.3M | $1.5M | $8.6M | $2.1M | $799.0K | $615.0K | $33.0K | ||||
| Share Based Compensation | $17.8M | $11.9M | $5.4M | $24.9M | $101.0K | $121.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$24.1M | -$33.1M | -$13.4M | -$5.3M | -$2.5M | -$7.1M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$5.7M | -$24.9M | -$34.0K | $0.00 | -$13.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.2M | $475.0K | $1.5M | $705.0K | -$219.0K | $10.0M | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $914.0K | $10.4M | $2.3M | $1.7M | -$346.0K | $1.3M | ||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$275.0K | $1.3M | -$493.0K | -$1.7M | $7.2M | -$109.0K | ||||||||||||
| Increase Decrease In Accounts Receivable | $72.5M | $55.3M | $71.3M | $48.8M | $17.6M | $14.9M | ||||||||||||
| Increase Decrease In Operating Lease Liability | -$155.0K | -$777.0K | -$694.0K | -$601.0K | $10.9M | $0.00 | ||||||||||||
| Proceeds From Stock Options Exercised | $2.2M | $475.0K | $1.5M | $799.0K | $0.00 | |||||||||||||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$5.3M | $673.0K | |||||||||||||||
| Increase Decrease In Accounts Payable | -$13.9M | -$7.2M | -$6.5M | -$1.7M | -$8.9M | $3.9M | ||||||||||||
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $707.0K | $24.9M | $0.00 | ||||||||||||||
| Proceeds From Minority Shareholders | $0.00 | $125.0K | $0.00 | |||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $34.0K | $0.00 | $13.0K | ||||||||||||||
| Proceeds From Issuance Initial Public Offering | ||||||||||||||||||
| Payments Of Stock Issuance Costs |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 128.9M | 125.6M | 124.7M | 110.7M | 103.0M | 96.0M | 95.9M |
| Earnings Per Share Diluted | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 | $0.33 | $0.09 |
| Earnings Per Share Basic | $0.19 | $0.12 | $0.20 | $-0.08 | $-1.83 | $0.33 | $0.09 |
| Weighted Average Number Of Shares Outstanding Basic | 122.2M | 119.4M | 116.7M | 110.7M | 103.0M | 96.0M | 95.9M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 150.0M | |
| Common Stock Shares Outstanding | 123.6M | 120.3M | 118.2M | 114.7M | 107.8M | 96.0M | |
| Common Stock Shares Issued | 123.6M | 120.3M | 118.2M | 114.7M | 107.8M | 96.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 128.8M | 128.4M | 127.8M | 125.8M | 125.3M | 125.1M | 124.9M | 124.6M | 124.3M | 124.8M | 108.7M | 108.1M | 105.9M | 102.7M | 96.0M | 96.0M | 95.9M | 95.9M |
| Earnings Per Share Diluted | $0.05 | $0.02 | $0.03 | $0.03 | $0.03 | $0.02 | $0.05 | $0.06 | $0.06 | $0.01 | $-0.10 | $-0.16 | $-0.09 | $-1.68 | $0.06 | $0.17 | $0.06 | $0.06 |
| Earnings Per Share Basic | $0.06 | $0.02 | $0.03 | $0.03 | $0.03 | $0.03 | $0.05 | $0.06 | $0.06 | $0.01 | $-0.10 | $-0.16 | $-0.09 | $-1.68 | $0.06 | $0.17 | $0.06 | $0.06 |
| Weighted Average Number Of Shares Outstanding Basic | 122.8M | 122.1M | 120.6M | 119.7M | 119.3M | 118.5M | 117.6M | 116.2M | 115.0M | 111.6M | 108.7M | 108.1M | 105.9M | 102.7M | 96.0M | 96.0M | 95.9M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 150.0M | |||
| Common Stock Shares Outstanding | 122.9M | 122.7M | 121.4M | 120.0M | 119.5M | 118.7M | 118.0M | 117.1M | 115.5M | 113.8M | 109.6M | 108.3M | 106.2M | 105.7M | 96.0M | |||
| Common Stock Shares Issued | 122.9M | 122.7M | 121.4M | 120.0M | 119.5M | 118.7M | 118.0M | 117.1M | 115.5M | 113.8M | 109.6M | 108.3M | 106.2M | 105.7M | 96.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $71.1M | $56.7M | $37.1M | $67.4M | $253.5M | $484.0K | $207.0K |
| Interest Paid Net | $251.0K | $285.0K | $40.0K | $713.0K | $888.0K | $1.9M | $9.2M |
| Depreciation | $739.0K | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | $784.0K |
| Additional Paid In Capital | $892.3M | $813.2M | $753.9M | $714.6M | $633.9M | $165.7M | |
| Noncontrolling Interest Increase From Business Combination | $1.7M | $24.9M | $125.0K | $28.8M | |||
| Physician And Practice Expense | $727.8M | $629.5M | $622.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $19.0M | $18.8M | $17.8M | $15.1M | $14.4M | $11.9M | $10.8M | $9.2M | $5.4M | $14.8M | $18.5M | $24.9M | $25.8M | $202.6M | $101.0K | $121.0K | $121.0K | $121.0K |
| Interest Paid Net | $0.00 | $93.0K | $22.0K | $368.0K | $308.0K | $323.0K | ||||||||||||
| Depreciation | $228.0K | $294.0K | $291.0K | $306.0K | $285.0K | $166.0K | ||||||||||||
| Additional Paid In Capital | $873.4M | $854.0M | $833.2M | $797.3M | $781.4M | $766.2M | $740.0M | $726.2M | $721.5M | $703.5M | $680.2M | $659.6M | $605.7M | $579.3M | $165.8M | |||
| Noncontrolling Interest Increase From Business Combination | $653.0K | $1.0M | $569.0K | $24.2M | $125.0K | |||||||||||||
| Physician And Practice Expense | $190.1M | $169.9M | $161.1M | $160.4M | $141.5M | $165.1M |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.